Target intelligence / Profile preview

Beta-tubulin (TUBB) (TUBB)

Target
TUBB
Molecular classification
Structural protein, GTP-binding protein, Other
01

Overview

Beta-tubulin is a highly conserved eukaryotic protein that polymerizes with alpha-tubulin to form microtubules, which are essential components of the cellular cytoskeleton [UniProt: P07437]. These dynamic structures play a fundamental role in cell division by forming the mitotic spindle, which is responsible for the precise segregation of chromosomes into daughter cells [PubMed: 21860390]. Beyond mitosis, microtubules are critical for maintaining cell polarity, facilitating intracellular trafficking of organelles and vesicles, and enabling cell movement through cilia and flagella [NIH: PMC3155166]. In clinical practice, beta-tubulin is a major therapeutic target for anti-cancer drugs, which interfere with microtubule dynamics to induce mitotic arrest and programmed cell death [StatPearls: NBK541084]. However, because microtubules are also vital for the structural integrity and transport mechanisms of neurons, drugs targeting this protein often cause significant side effects, most notably peripheral neuropathy [PubMed: 25236393]. Resistance to tubulin-binding agents is frequently associated with the differential expression of specific beta-tubulin isotypes, such as TUBB3, making it a key area of study for personalized oncology [PubMed: 20570927].

Other names
Tubulin beta chainMicrotubule subunitTUBB family
02

Mechanism of action

Microtubule-targeting agents (MTAs) act via two primary mechanisms: 1) Microtubule stabilization, where drugs like taxanes and epothilones bind to the beta-tubulin subunit within the microtubule polymer, decreasing the critical concentration of tubulin required for assembly and preventing disassembly; 2) Microtubule destabilization, where drugs like vinca alkaloids and colchicine bind to tubulin dimers to inhibit their polymerization into microtubules. Both mechanisms interfere with the dynamic instability of the mitotic spindle, leading to cell cycle arrest at the G2/M phase and subsequent apoptosis [StatPearls: NBK541084; PubMed: 24507545].

03

Biological functions

Cell cycleCell proliferationCell motilityIntracellular transportOther
04

Disease associations

CancerInflammationNeurodegenerative diseaseOther
05

Safety considerations

Peripheral neuropathyMyelosuppressionNeutropeniaAlopeciaGastrointestinal toxicity
06

Interacting drugs

Paclitaxel

8 more in the full profile.

07

Biomarkers

Class III beta-tubulin (TUBB3) expressionTau protein (MAPT) levelsStathmin-1 (STMN1) expression

Beyond the preview

Go deeper on Beta-tubulin (TUBB) (TUBB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-tubulin (TUBB) (TUBB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call